ARATANA THERAPEUTICS, INC. Research and Development in Process
ARATANA THERAPEUTICS, INC. reported Research and Development in Process of $2.16 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-14.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2017-03-14
- ARATANA THERAPEUTICS, INC. research and development in process for the quarter ending 2014-12-31 was $1.00M.
- ARATANA THERAPEUTICS, INC. research and development in process for the quarter ending 2014-09-30 was $0.00.
- ARATANA THERAPEUTICS, INC. research and development in process for the quarter ending 2014-06-30 was $500.00K.
- ARATANA THERAPEUTICS, INC. research and development in process for the quarter ending 2014-03-31 was $657.00K.
- ARATANA THERAPEUTICS, INC. research and development in process for fiscal 2014 was $2.16M.
- ARATANA THERAPEUTICS, INC. research and development in process for fiscal 2012 was $1.50M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month | Research and Development in Process 31 month | Research and Development in Process 34 month | Research and Development in Process 37 month | Research and Development in Process 40 month |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $1.00M derived: sum of 2 quarters · filed 2017-03-14 | $1.50M derived: sum of 3 quarters · filed 2017-03-14 | $2.16M 10-K · filed 2017-03-14 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $500.00K derived: sum of 2 quarters · filed 2015-11-06 | $1.16M 10-Q · filed 2015-11-06 | |||||
| 2014-06-30 | $500.00K 10-Q · filed 2015-08-07 | $1.16M 10-Q · filed 2015-08-07 | ||||||
| 2014-03-31 | $657.00K 10-Q · filed 2015-05-08 | $8.68M 10-Q · filed 2014-05-15 | ||||||
| 2013-12-31 | $8.03M 10-K · filed 2014-03-26 | |||||||
| 2013-09-30 | $8.03M 10-Q · filed 2013-11-14 | |||||||
| 2013-06-30 | $8.03M 10-Q · filed 2013-08-13 | |||||||
| 2012-12-31 | $1.50M 10-K · filed 2015-03-16 |